Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2013 · 10-Q
Revenue$97.07M$97.07M+3.7% vs Q2 2012 Net Income$7.07M$7.07M+151.4% vs Q2 2012 EPS Diluted$0.51$0.51+155.0% vs Q2 2012 Gross Profit$72,930,000+4.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$12,937,000+20.4% Free Cash Flowderived$9,895,000+25.5% Margins · derivedGross margin75.1%+0.2 pt vs Q2 2012
Operating margin11.0%+6.0 pt vs Q2 2012
Net margin7.3%+4.3 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 9, 2013 · 40 d after period end